| Website | fibrogen.com |
| Category | BioTech |
| Phone | 415-978-1200 |
| Employees |
| TOTAL | $100M |
| VENTURE FUNDING TOTAL | $100M |
| Venture Round, 2/05 Adage Capital Management Apothecary Capital Brookside Capital Corriente Biotechnology Partners Duquesne Goldman Sachs Janus Merlin Biomed Och-Ziff Capital Management Sigma Capital T. Rowe Price Daiwa SMBC Capital BioFund Management | $100M |
FibroGen is a research-based biotechnology company using its expertise in connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology to discover, develop, and commercialize novel therapeutics for serious unmet medical needs.
